Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1998 Jun;53(6):454–458. doi: 10.1136/thx.53.6.454

Cross sectional study of exhaled nitric oxide levels following lung transplantation

A Fisher 1, E Gabbay 1, T Small 1, S Doig 1, J Dark 1, P Corris 1
PMCID: PMC1745250  PMID: 9713443

Abstract

BACKGROUND—The role of nitric oxide (NO) in the pathophysiology of graft dysfunction following lung transplantation remains unclear. To determine whether measurement of NO in the exhaled breath of lung transplant recipients provides useful information about graft pathology, a cross sectional study was performed on a cohort of recipients as they attended for review.
METHODS—One hundred and four lung transplant recipients and 55 healthy non-smoking controls were included in the study. Each subject performed three consecutive single breath NO manoeuvres. In recipients NO levels were compared according to current clinical status, presence of any graft pathology, type of lung transplant procedure, indication for transplantation, and current level of immunosuppression.
RESULTS—Mean (SE) exhaled NO levels were 6.5 (0.61) ppb in the control group, 5.3 (0.46) in clinically well recipients, 10.3 (1.4) in those with lymphocytic bronchiolitis, 10.5 (1.0) in recipients with infection, and 2.5 (0.6) in those with acute vascular rejection. There was no significant difference in NO levels between the control group and lung transplant recipients as a whole (mean difference 0.29 (95% CI -1.17 to 1.75), p = 0.7). Levels were increased significantly in the presence of lymphocytic bronchiolitis (4.98 (95% CI 1.6to 8.36), p = 0.0002) and infection (5.28 (95% CI 2.9 to 7.56), p<0.0001), but not in acute vascular rejection (2.76 (95% CI 0.97to 4.55), p = 0.1) compared with exhaled NO in clinically well recipients. Recipients with obliterative bronchiolitis were subdivided according to the grade of their bronchiolitis obliterans syndrome (BOS). Exhaled NO levels in those with BOS grade 1 were 10.0 (1.3) ppb and in those with BOS grades 2 or 3 were 5.1 (0.7) ppb. Compared with those who were clinically well, NO levels were increased in those with BOS grade 1 (4.74 (95% CI 1.8 to 7.69), p < 0.0001) but not in those with BOS grades 2 or 3 (0.19 (95% CI -1.55 to 1.93), p = 0.82).
CONCLUSIONS—Exhaled NO levels are increased in lung transplant recipients with lymphocytic bronchiolitis, early obliterative bronchiolitis, and infection. These conditions are all associated with the presence of airway inflammation within the graft. The findings suggest that exhaled NO measurements may have a role as a marker of pulmonary allograft dysfunction.



Full Text

The Full Text of this article is available as a PDF (115.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Kharitonov S. A. Exhaled nitric oxide: a new lung function test. Thorax. 1996 Mar;51(3):233–237. doi: 10.1136/thx.51.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borland C., Cox Y., Higenbottam T. Measurement of exhaled nitric oxide in man. Thorax. 1993 Nov;48(11):1160–1162. doi: 10.1136/thx.48.11.1160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cooper J. D., Billingham M., Egan T., Hertz M. I., Higenbottam T., Lynch J., Mauer J., Paradis I., Patterson G. A., Smith C. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993 Sep-Oct;12(5):713–716. [PubMed] [Google Scholar]
  4. Devlin J., Palmer R. M., Gonde C. E., O'Grady J., Heaton N., Tan K. C., Martin J. F., Moncada S., Williams R. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation. 1994 Sep 15;58(5):592–595. [PubMed] [Google Scholar]
  5. Kharitonov S. A., Barnes P. J. Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding. Thorax. 1997 Jun;52(6):540–544. doi: 10.1136/thx.52.6.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kharitonov S. A., Wells A. U., O'Connor B. J., Cole P. J., Hansell D. M., Logan-Sinclair R. B., Barnes P. J. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med. 1995 Jun;151(6):1889–1893. doi: 10.1164/ajrccm.151.6.7767536. [DOI] [PubMed] [Google Scholar]
  7. Kharitonov S. A., Yates D., Robbins R. A., Logan-Sinclair R., Shinebourne E. A., Barnes P. J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994 Jan 15;343(8890):133–135. doi: 10.1016/s0140-6736(94)90931-8. [DOI] [PubMed] [Google Scholar]
  8. Kharitonov S., Alving K., Barnes P. J. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J. 1997 Jul;10(7):1683–1693. doi: 10.1183/09031936.97.10071683. [DOI] [PubMed] [Google Scholar]
  9. Maurer J. R., Morrison D., Winton T. L., Patterson G. A. Late pulmonary complications of isolated lung transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1224–1225. [PubMed] [Google Scholar]
  10. Persson M. G., Zetterström O., Agrenius V., Ihre E., Gustafsson L. E. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet. 1994 Jan 15;343(8890):146–147. doi: 10.1016/s0140-6736(94)90935-0. [DOI] [PubMed] [Google Scholar]
  11. Singh S., Evans T. W. Nitric oxide, the biological mediator of the decade: fact or fiction? Eur Respir J. 1997 Mar;10(3):699–707. [PubMed] [Google Scholar]
  12. Tazelaar H. D., Yousem S. A. The pathology of combined heart-lung transplantation: an autopsy study. Hum Pathol. 1988 Dec;19(12):1403–1416. doi: 10.1016/s0046-8177(88)80233-8. [DOI] [PubMed] [Google Scholar]
  13. Theodore J., Lewiston N. Lung transplantation comes of age. N Engl J Med. 1990 Mar 15;322(11):772–774. doi: 10.1056/NEJM199003153221110. [DOI] [PubMed] [Google Scholar]
  14. Valentine V. G., Robbins R. C., Berry G. J., Patel H. R., Reichenspurner H., Reitz B. A., Theodore J. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant. 1996 Apr;15(4):371–383. [PubMed] [Google Scholar]
  15. Wiklund L., Lewis D. H., Sjöquist P. O., Nilsson F., Tazelaar H., Miller V. M., McGregor C. G. Increased levels of circulating nitrates and impaired endothelium-mediated vasodilation suggest multiple roles of nitric oxide during acute rejection of pulmonary allografts. J Heart Lung Transplant. 1997 May;16(5):517–523. [PubMed] [Google Scholar]
  16. Winlaw D. S., Schyvens C. G., Smythe G. A., Du Z. y., Rainer S. P., Keogh A. M., Mundy J. A., Lord R. S., Spratt P. M., MacDonald P. S. Urinary nitrate excretion is a noninvasive indicator of acute cardiac allograft rejection and nitric oxide production in the rat. Transplantation. 1994 Nov 15;58(9):1031–1036. doi: 10.1097/00007890-199411150-00010. [DOI] [PubMed] [Google Scholar]
  17. Yousem S. A., Berry G. J., Cagle P. T., Chamberlain D., Husain A. N., Hruban R. H., Marchevsky A., Ohori N. P., Ritter J., Stewart S. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant. 1996 Jan;15(1 Pt 1):1–15. [PubMed] [Google Scholar]
  18. Yousem S. A. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol. 1993 May;17(5):491–496. doi: 10.1097/00000478-199305000-00008. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES